HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ASA Not Sweet On Cough Claims For Honey

Executive Summary

There are no circumstances when a food can claim to treat human disease, even when this goes against public health guidance, rules the UK's Advertising Standards Authority in case brought against a New Zealand-based manuka honey company.

You may also be interested in...



US COVID-19 Fraud: IV Drip Provider Reconsiders Claims, Bee Honey Joins List Of Unapproved Cures

New York business reconsiders claiming intravenous drips of vitamin blends prevent COVID-19 infections after industry group forwarded concerns to regulators. Latest natural health remedy linked to fraudulent COVID-19 treatment claims is honey from marketers’ beehives.

COVID-19 Mentions Prohibited From Supplement Ads - UK Regulator

Dietary supplement ads should not make any explicit or implicit references to COVID-19, with immunity boosting claims also strictly off limits, says UK regulator the Advertising Standards Authority.

OTCs over antibiotics in instance of acute cough

OTC medicines and honey are being advocated by the National Institute for Health and Clinical Excellence (NICE) in England and Wales as the first line of treatment for acute cough rather than antibiotics. NICE has issued the draft guidance in line with efforts to limit the use of antibiotics and reduce resistance.

Topics

UsernamePublicRestriction

Register

ID1131849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel